These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 9776294

  • 1. Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
    Goodwin DA, Meares CF, Osen M.
    J Nucl Med; 1998 Oct; 39(10):1813-8. PubMed ID: 9776294
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
    Goodwin DA, Meares CF, Watanabe N, McTigue M, Chaovapong W, Ransone CM, Renn O, Greiner DP, Kukis DL, Kronenberger SI.
    Cancer Res; 1994 Nov 15; 54(22):5937-46. PubMed ID: 7954426
    [Abstract] [Full Text] [Related]

  • 3. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM, Beaumier P, Axworthy D, Atcher R, Fritzberg A.
    Nucl Med Biol; 2005 Oct 15; 32(7):741-7. PubMed ID: 16243650
    [Abstract] [Full Text] [Related]

  • 4. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H, Sharkey RM, Govindan SV, McBride WJ, Goldenberg DM, Hansen HJ, Griffiths GL.
    Bioconjug Chem; 1997 Oct 15; 8(4):585-94. PubMed ID: 9258459
    [Abstract] [Full Text] [Related]

  • 5. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P, Luison E, Ménard S, Colnaghi MI, Paganelli G, Canevari S.
    J Nucl Med; 1997 Sep 15; 38(9):1378-81. PubMed ID: 9293791
    [Abstract] [Full Text] [Related]

  • 6. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM, Karacay H, Griffiths GL, Behr TM, Blumenthal RD, Mattes MJ, Hansen HJ, Goldenberg DM.
    Bioconjug Chem; 1997 Sep 15; 8(4):595-604. PubMed ID: 9258460
    [Abstract] [Full Text] [Related]

  • 7. Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
    Lubic SP, Goodwin DA, Meares CF, Song C, Osen M, Hays M.
    J Nucl Med; 2001 Apr 15; 42(4):670-8. PubMed ID: 11337558
    [Abstract] [Full Text] [Related]

  • 8. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA.
    J Nucl Med; 1997 Dec 15; 38(12):1951-9. PubMed ID: 9430476
    [Abstract] [Full Text] [Related]

  • 9. Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
    Hamblett KJ, Press OW, Meyer DL, Hamlin DK, Axworthy D, Wilbur DS, Stayton PS.
    Bioconjug Chem; 2005 Dec 15; 16(1):131-8. PubMed ID: 15656584
    [Abstract] [Full Text] [Related]

  • 10. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
    Goodwin DA, Meares CF, McCall MJ, Haseman MK, McTigue M, Diamanti CI, Chaovapong W.
    J Nucl Med; 1985 May 15; 26(5):493-502. PubMed ID: 3921673
    [Abstract] [Full Text] [Related]

  • 11. Pretargeted radioimmunotherapy of cancer: progress step by step.
    Boerman OC, van Schaijk FG, Oyen WJ, Corstens FH.
    J Nucl Med; 2003 Mar 15; 44(3):400-11. PubMed ID: 12621007
    [Abstract] [Full Text] [Related]

  • 12. Effect of metabolism on retention of indium-111-labeled monoclonal antibody in liver and blood.
    Kinuya S, Jeong JM, Garmestani K, Saga T, Camera L, Brechbiel MW, Gansow OA, Carrasquillo JA, Neumann RD, Paik CH.
    J Nucl Med; 1994 Nov 15; 35(11):1851-7. PubMed ID: 7965168
    [Abstract] [Full Text] [Related]

  • 13. Pretargeted radioimmunotherapy of mesothelin-expressing cancer using a tetravalent single-chain Fv-streptavidin fusion protein.
    Sato N, Hassan R, Axworthy DB, Wong KJ, Yu S, Theodore LJ, Lin Y, Park L, Brechbiel MW, Pastan I, Paik CH, Carrasquillo JA.
    J Nucl Med; 2005 Jul 15; 46(7):1201-9. PubMed ID: 16000290
    [Abstract] [Full Text] [Related]

  • 14. Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
    Shen S, Forero A, LoBuglio AF, Breitz H, Khazaeli MB, Fisher DR, Wang W, Meredith RF.
    J Nucl Med; 2005 Apr 15; 46(4):642-51. PubMed ID: 15809487
    [Abstract] [Full Text] [Related]

  • 15. Pretargeted radioimmunotherapy.
    Meredith RF, Buchsbaum DJ.
    Int J Radiat Oncol Biol Phys; 2006 Apr 15; 66(2 Suppl):S57-9. PubMed ID: 16979441
    [Abstract] [Full Text] [Related]

  • 16. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
    Borchardt PE, Quadri SM, Freedman RS, Vriesendorp HM.
    J Nucl Med; 1998 Mar 15; 39(3):476-84. PubMed ID: 9529295
    [Abstract] [Full Text] [Related]

  • 17. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG, Oosterwijk E, Molkenboer-Kuenen JD, Soede AC, McBride BJ, Goldenberg DM, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Mar 15; 46(3):495-501. PubMed ID: 15750164
    [Abstract] [Full Text] [Related]

  • 18. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
    Wilbur DS, Hamlin DK, Vessella RL, Stray JE, Buhler KR, Stayton PS, Klumb LA, Pathare PM, Weerawarna SA.
    Bioconjug Chem; 1996 Mar 15; 7(6):689-702. PubMed ID: 8950488
    [Abstract] [Full Text] [Related]

  • 19. Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.
    van Schaijk FG, Broekema M, Oosterwijk E, van Eerd JE, McBride BJ, Goldenberg DM, Corstens FH, Boerman OC.
    J Nucl Med; 2005 Jun 15; 46(6):1016-22. PubMed ID: 15937314
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L, Kinuya S, Garmestani K, Wu C, Brechbiel MW, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH.
    J Nucl Med; 1994 May 15; 35(5):882-9. PubMed ID: 8176477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.